The Mumbai-based drug maker said it has acquired Ondero and Ondero Met, including the trademark rights associated with these brands. Lupin has been marketing the two brands since 2015 in the Indian market as part of a co-marketing agreement with Boehringer Ingelheim India.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment